Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Radiation-induced cytotoxicity refers to the various forms of cell death and cellular damage caused by exposure to ionizing radiation. When cells are irradiated, direct damage to DNA—particularly double strand breaks—triggers multiple forms of cell death such as apoptosis, necrosis, autophagy-dependent cell death, pyroptosis, ferroptosis, and immunogenic cell death[2][5]. In addition to DNA damage, radiation generates reactive oxygen species (ROS), induces endoplasmic reticulum stress, and activates damage-associated molecular patterns (DAMPs) like calreticulin, HMGB1, and ATP, which promote immune responses and inflammation[1][2][3]. Radiation cytotoxicity also involves the release of cytokines such as IL-1, IL-6, TNF-α, and TGF-β, leading to chronic inflammation and tissue fibrosis in normal tissues[3]. This process is clinically relevant in both radiation therapy for cancer—where it is exploited to kill tumor cells—and in the context of normal tissue toxicity and side effects of radiotherapy[3][5].\n \n**Note:** "Radiation-induced cytotoxicity" is a process, not a single druggable target. If you are seeking specific molecular targets involved in mediating or sensing radiation cytotoxicity (such as DNA damage response proteins, purinergic receptors, or cytokine receptors), these should be named specifically (e.g., "DNA-dependent protein kinase," "P2X7 purinergic receptor") for structured data extraction[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radiation-induced cytotoxicity.